Skip to main content Back to Top
Advertisement

11/27/2019

Heparin Sodium Premixed Bags

Products Affected - Description

    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/500 mL in 0.9% Sodium Chloride, premixed bag, 18 count, NDC 00409-7620-03
    • Heparin Sodium solution for injection, Pfizer, 12,500 unit/250 mL in 0.45% Sodium Chloride, premixed bag, 24 count, NDC 00409-7651-62
    • Heparin Sodium solution for injection, Pfizer, 2,000 unit/1000 mL in 0.9% Sodium Chloride, premixed bag, 12 count, NDC 00409-7620-59
    • Heparin Sodium solution for injection, Pfizer, 25,000 unit/250 mL in 0.45% Sodium Chloride, premixed bag, 24 count, NDC 00409-7650-62
    • Heparin Sodium solution for injection, Pfizer, 25,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count, NDC 00409-7793-62
    • Heparin Sodium solution for injection, Pfizer, 25,000 unit/500 mL in 0.45% Sodium Chloride, premixed bag, 24 count, NDC 00409-7651-03

Reason for the Shortage

    • Baxter has heparin premix available.
    • BBraun has heparin premixes available.
    • Fresenius Kabi has put heparin on a protective allocation due to a potential shortage of raw ingredient. The letter describing this in detail is available at the following link: https://www.fresenius-kabi.com/us/news/fresenius-kabi-responds-to-a-potential-shortage-of-heparin.
    • Pfizer has heparin on shortage due to manufacturing delays.

Available Products

    • Heparin Sodium solution for injection, BBraun, 1,000 unit/500 mL in 0.9% Sodium Chloride, premixed bag, 24 count, NDC 00264-9872-10
    • Heparin Sodium solution for injection, BBraun, 20,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count, NDC 00264-9567-10
    • Heparin Sodium solution for injection, BBraun, 25,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count, NDC 00264-9587-20
    • Heparin Sodium solution for injection, BBraun, 25,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count, NDC 00264-9577-10
    • Heparin Sodium solution for injection, Baxter, 2,000 unit/1000 mL in 5% Dextrose, premixed bag, 12 count, NDC 00338-0433-04
    • Heparin Sodium solution for injection, Fresenius Kabi, 25,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count, NDC 63323-0523-74
    • Heparin Sodium solution for injection, Fresenius Kabi, 25,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count, NDC 63323-0522-77
    • Heparin Sodium solution for injection, Fresenius Kabi, 25,500 unit/250 mL in 0.45% Sodium Chloride, premixed bag, 24 count, NDC 63323-0517-74
    • Heparin Sodium solution for injection, Fresenius Kabi, 25,500 unit/500 mL in 0.45% Sodium Chloride, premixed bag, 24 count, NDC 63323-0518-77

Estimated Resupply Dates

    • Pfizer has all heparin premixed bags are available in limited supply.

Updated

Updated November 27, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins